(Q59306907)
Statements
A randomized, double-blind trial on the use of a triple combination including nevirapine, a nonnucleoside reverse transcriptase HIV inhibitor, in antiretroviral-naive patients with advanced disease (English)
R Bucciardini
D Ricciardulli
V Fragola
M F Pirillo
L E Weimer
C Tomino
G Giannini
C M Galluzzo
M Andreotti
A Cargnel
F Alberici
B De Rienzo
F Leoncini
F Fiaccadori
D Francisci
W Grillone
L Ortona
M Piazza
A Scalzini
E Nigra
F Tumietto
1 January 1999